HOME >> MEDICINE >> NEWS
People Who Are Diabetic And Glucose Intolerant Can Benefit From "Statin" Drug Therapy, Even If Cholesterol Levels Are Normal

DALLAS, Dec. 8 -- A cholesterol-lowering drug may help reduce the risk of another heart attack and the need for artery-opening procedures in people with diabetes and heart disease who have average blood levels of cholesterol, according to a study in today's issue of Circulation: Journal of the American Heart Association.

The study involved a subgroup of 586 diabetic individuals in the Cholesterol and Recurrent Events (CARE) trial, a five-year study that compared therapy using the drug pravastatin to placebo in men and women who had a previous heart attack and average blood levels of cholesterol.

"Although diabetes is a major risk factor for heart disease, little information is available on the effects of cholesterol-lowering therapies in individuals with diabetes," says co-author Frank M. Sacks, M.D., associate professor of medicine at Harvard Medical School and Brigham and Women's Hospital, Boston. Because the CARE trial population -- a total of 4,159 patients from 80 clinical centers in the United States and Canada -- included a large number of individuals, scientists had enough data to determine whether pravastatin therapy reduced the risk of recurrent heart attack or the need for treatment to unblock the arteries in people with diabetes.

Pravastatin is one of the statin class of cholesterol-lowering drugs called HMG CoA inhibitors.

Sacks reports that, compared with those in the placebo group, diabetic patients who received pravastatin had a 25 percent reduction in relative risk of having another heart attack. The relative risk of needing coronary artery bypass or angioplasty to unblock blood vessels was reduced by 32 percent in the statin-treated group.

The researchers also analyzed data from a subgroup of 342 people without diabetes who met the American Diabetes Association's definition of being glucose intolerant (fasting blood glucose levels between 110 to 125 mg/dL). "This subgroup had a higher rate of coronary events, such as recu
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
7-Dec-1998


Page: 1 2

Related medicine news :

1. People wounded in tsunami at risk of undetected fungal infections
2. People on food stamps cant afford heart-healthy meals
3. People are of two minds on moral judgments
4. People with low incomes more likely to develop brain tumors
5. People are averse to taking drugs
6. People with chronic eye diseases not getting recommended eye exams
7. People with large pupils can now get LASIK and avoid night vision disturbances
8. People only slightly more likely to die after episodes of stagnant air
9. People with food allergies should not only be careful about what they eat
10. People who give, live longer: U-M study shows
11. People near freeways are exposed to 30 times the concentration of dangerous particles

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... July 23, 2019 , ... Denver-based Blue Dog Designs, makers of the ... (CRI), is pleased to announce the winner of the 2019 Help ‘Em Out ... technician at Blue Pearl Veterinary Partners of New York. Previously, Arbitman ...
(Date:7/23/2019)... ... July 23, 2019 , ... Nightingale College, a fully accredited ... programs to Dodge City and Manhattan, Kansas. Local hospitals and health care facilities ... accessible by allowing learners the flexibility of completing all didactic courses online and ...
(Date:7/23/2019)... MILFORD, Pa. (PRWEB) , ... July 23, 2019 , ... ... has recently launched a new online custom pipe marker designer , allowing customers ... tool provides design flexibility and convenience and takes just minutes to use. , ...
(Date:7/23/2019)... ... 23, 2019 , ... Ziegler, a national specialty investment bank, ... companies that provide products, services and technology to the aging marketplace, announced today ... to 5:00 p.m. at Ziegler’s corporate headquarters, located at One North Wacker in ...
(Date:7/23/2019)... ... July 23, 2019 , ... NeoTract, a wholly owned ... of urology, today announced that Bradley Wilson, MD, Norman Urology Associates in Norman, ... that Dr. Wilson has achieved a high level of training and experience with ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... , ... July 19, 2019 , ... ... vasodilator) device. D’OXYVA is a novel non-invasive transdermal (over-the-skin) technology, which is the ... depth and breadth of the clinical evidence obtained by Circularity over the past ...
(Date:7/19/2019)... , ... July 19, 2019 , ... ... a GLC company, has named Jorge Bacigalupo Director of Education Strategy. , ... currently includes education delivered on six continents and in ten languages. AGILE has ...
(Date:7/18/2019)... ... 18, 2019 , ... Joining PAINWeek, the largest US pain ... courses on Saturday, September 7. PAINWeek faculty members James Fricton, DDS, MS, President ... Member and Pain Specialist, will lead these skills training courses, Transformative Care for ...
Breaking Medicine Technology:
Cached News: